Trial intelligence / Profile preview

Intracavernous Self-Injection Therapy with PGE1 for Erectile Dysfunction

jRCT1051240270Not yet recruiting

Sponsor
Osaka Umeda Shinshi Clinic
Start
Feb 2025
Modality
Small Molecules
Countries
1
01

Overview

Open-label, single-arm trial of Vasostenoon in erectile dysfunction (ED), sponsored by Osaka Umeda Shinshi Clinic. Primary endpoint: International Index of Erectile Function-5 (IIEF-5) score. Planned start Feb 2025; status: not yet recruiting.

02

Drugs

Vasostenoon
03

Conditions

erectile dysfunction (ED)

Beyond the preview

Go deeper on jRCT1051240270.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT1051240270.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call